Transmyocardial Revascularization Enhances Bone Marrow Stem Cell Engraftment in Infarcted Hearts Through SCF—C-kit and SDF-1—CXCR4 Signaling Axes

[1]  Yu-yu Yao,et al.  Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1α , 2013, PloS one.

[2]  Xiaoning Zhao,et al.  Short-term intermittent administration of CXCR4 antagonist AMD3100 facilitates myocardial repair in experimental myocardial infarction. , 2013, Acta biochimica et biophysica Sinica.

[3]  Joshua M Hare,et al.  Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. , 2012, JAMA.

[4]  T. Yau,et al.  Transmyocardial revascularization induces mesenchymal stem cell engraftment in infarcted hearts. , 2012, The Annals of thoracic surgery.

[5]  Dejian Lai,et al.  Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. , 2012, JAMA.

[6]  Jing Liu,et al.  Transmyocardial drilling revascularization combined with heparinized bFGF-incorporating stent activates resident cardiac stem cells via SDF-1/CXCR4 axis. , 2012, Experimental cell research.

[7]  J. Hare,et al.  Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. , 2011, Circulation research.

[8]  Shengshou Hu,et al.  Low-level laser irradiation alters cardiac cytokine expression following acute myocardial infarction: a potential mechanism for laser therapy. , 2011, Photomedicine and laser surgery.

[9]  Shao‐xin Zheng,et al.  Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction , 2011, Journal of cellular and molecular medicine.

[10]  Minhyung Lee,et al.  Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  A. Arai,et al.  Does laser type impact myocardial function following transmyocardial laser revascularization? , 2010, Lasers in surgery and medicine.

[12]  M. Tomasson,et al.  CXCR4-Mediated Bone Marrow Progenitor Cell Maintenance and Mobilization Are Modulated by c-kit Activity , 2010, Circulation research.

[13]  Y. Luan,et al.  Mechanisms of the protective effects of BMSCs promoted by TMDR with heparinized bFGF-incorporated stent in pig model of acute myocardial ischemia , 2010, Journal of cellular and molecular medicine.

[14]  H. Thiele,et al.  Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial , 2009, American heart journal.

[15]  A. Keating,et al.  Bone Marrow-derived Mesenchymal Stromal Cells Express Cardiac-specific Markers, Retain the Stromal Phenotype, and Do Not Become Functional Cardiomyocytes in Vitro Departments of a Physiology And , 2022 .

[16]  D. Kraitchman,et al.  Serial Noninvasive In Vivo Positron Emission Tomographic Tracking of Percutaneously Intramyocardially Injected Autologous Porcine Mesenchymal Stem Cells Modified for Transgene Reporter Gene Expression , 2008, Circulation. Cardiovascular imaging.

[17]  E. Daon,et al.  Transmyocardial laser revascularization: from randomized trials to clinical practice. A review of techniques, evidence-based outcomes, and future directions. , 2008, Anesthesiology clinics.

[18]  Peter R. Brink,et al.  Culturing of Human Mesenchymal Stem Cells as Three-dimensional Aggregates Induces Functional Expression of CXCR4 That Regulates Adhesion to Endothelial Cells* , 2008, Journal of Biological Chemistry.

[19]  Guang-qian Zhou,et al.  SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model , 2008, Brain Research.

[20]  R. Weisel,et al.  Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival. , 2007, American journal of physiology. Heart and circulatory physiology.

[21]  Amit N. Patel,et al.  Improved Cell Survival in Infarcted Myocardium Using a Novel Combination Transmyocardial Laser and Cell Delivery System , 2007, Cell transplantation.

[22]  S. Rafii,et al.  The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. , 2007, Trends in immunology.

[23]  S. Fazel,et al.  Enhanced angiogenesis with multimodal cell-based gene therapy. , 2007, The Annals of thoracic surgery.

[24]  E. Gagari,et al.  Expression of stem cell factor and its receptor, c-kit, in human oral mesenchymal cells. , 2006, European journal of oral sciences.

[25]  R. Weisel,et al.  Maximizing Ventricular Function With Multimodal Cell-Based Gene Therapy , 2005, Circulation.

[26]  Ping Zhang,et al.  Radiolabeled Cell Distribution After Intramyocardial, Intracoronary, and Interstitial Retrograde Coronary Venous Delivery: Implications for Current Clinical Trials , 2005, Circulation.

[27]  M. Ratajczak,et al.  Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF‐1–CXCR4 Axis , 2005, Stem cells.

[28]  E. Bonifacio,et al.  Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. , 2005, Blood.

[29]  H. Arnesen,et al.  Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects , 2005, Scandinavian cardiovascular journal : SCJ.

[30]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[31]  W. Baumgartner,et al.  Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. , 2002, The Annals of thoracic surgery.

[32]  D. McPherson,et al.  Functional comparison of transmyocardial revascularization by mechanical and laser means. , 2001, The Annals of thoracic surgery.

[33]  N. Sharpe,et al.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.

[34]  Zaheer Yousef,et al.  Postinfarction Left Ventricular Remodeling: A Pathophysiological and Therapeutic Review , 2000, Cardiovascular Drugs and Therapy.

[35]  L. Ashman,et al.  The biology of stem cell factor and its receptor C-kit. , 1999, The international journal of biochemistry & cell biology.

[36]  G. Hutchins,et al.  Cardiac sympathetic denervation after transmyocardial laser revascularization. , 1999, Circulation.

[37]  B. Wandt,et al.  Echocardiographic assessment of ejection fraction in left ventricular hypertrophy , 1999, Heart.

[38]  M. Ballmaier,et al.  Downregulation of c-kit expression in human endothelial cells by inflammatory stimuli. , 1997, Blood.

[39]  M. Caligiuri,et al.  The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Welte,et al.  Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation. , 1994, Blood.

[41]  Yu-yu Yao,et al.  Regulation of c-kit+ progenitor cells by stromal cell derived factor-1α in adult murine heart. , 2014, Heart, lung & circulation.

[42]  Michael Bader,et al.  SDF-1α as a therapeutic stem cell homing factor in myocardial infarction. , 2011, Pharmacology & therapeutics.

[43]  D. Cooley,et al.  Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency. , 1994, Texas Heart Institute journal.

[44]  R Gorlin,et al.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. , 1976, The American journal of cardiology.